A study in the most recent issue of the European Journal of Gastroenterology reports a change in awareness of gluten-related disorders among chefs and the general public in the United Kingdom.
PPIs partially restore mucosal integrity in patients with PPI–responsive esophageal eosinophilia but not eosinophilic esophagitis, reports the most recent issue of Clinical Gastroenterology & Hepatology.
A study in the most recent publication of the Clinial Gastroenterology & Gastroenterology evaluates the use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.
A study in this month's issue of the American Journal of Gastroenterology evaluates the impact of baseline risk, bleeding severity, and process of care in hospitalized patients with GI bleeding.
The latest issue of the Clinical Gastroenterology & Hepatology evaluates the association between thiopurines and risk of colorectal neoplasia in patients with IBD.
A Rome Foundation working team report examines multinational, cross-cultural research in the functional gastrointestinal disorders, reports November's issue of the Alimentary Pharmacology & Therapeutics.
Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival, reports the latest issue of the Alimentary Pharmacology & Therapeutics.
A study in November's issue of the Alimentary Pharmacology & Therapeutics evaluates the prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidemia.
This month's American Journal of Gastroenterology compares pretreatment antimicrobial susceptibility-guided with clarithromycin-based triple therapy for H pylori eradication in a region with high rates of multiple drug resistance.
The latest issue of the Alimentary Pharmacology & Therapeutics examines the sequential organ failure assessment score for mortality in critically ill cirrhotic patients.
A study in November's issue of the Alimentary Pharmacology & Therapeutics examines the association between aspirin use and the prevalence of nonalcoholic fatty liver disease.
Pretreatment antimicrobial susceptibility-guided vs clarithromycin-based triple therapy for H pylori eradication in a region with high rates of multiple drug resistance.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .